Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,818.50
(
-0.09%
)
US TECH 100
24,420.00
(
0.05%
)
Dow Jones
47,928.18
(
-0.53%
)
Brent Oil
94.88
(
0.45%
)
Bitcoin
72,922.99
(
1.58%
)
News Focus
News Focus
Post# of 257375
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

hptaxis

Send PM Follow Ignore
Followers 16
Posts 1775
Boards Moderated 0
Alias Born 08/05/2008

hptaxis

Re: mcbio post# 134420

Wednesday, 01/11/2012 11:19:57 AM

Wednesday, January 11, 2012 11:19:57 AM

Post# of 257375
Isis CEO Predicts Success For His Cholesterol Medicine -- And Substantial Delays For Regeneron, Pfizer And Amgen
http://www.forbes.com/sites/matthewherper/2012/01/11/isis-ceo-predicts-success-for-his-cholesterol-medicine-and-substantial-delays-for-regeneron-pfizer-and-amgen/

Isis Pharmaceuticals chief executive Stanley Crooke thinks that Wall Street is wildly undervaluing the cholesterol drug he is developing with drug giant Sanofi’s Genzyme unit – and that there may be substantial delays for another type of medicine that could be a competitor down the road.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today